全球經腸營養市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

經腸營養市場預計將從 2025 年的 73 億美元成長到 2034 年的 125.2 億美元，2026 年至 2034 年的複合年成長率為 6.17%。

由於吞嚥障礙和營養不良患者對營養支持的需求不斷成長，經腸營養市場正經歷顯著成長。經腸營養專為那些難以經口攝取營養的人而設計，例如慢性病患者、神經系統疾病患者以及術後復健患者。癌症、中風和胃腸道疾病等疾病發生率的上升也推動了對經腸營養解決方案的需求。隨著醫療保健機構努力確保患者獲得適當的營養，經腸營養市場預計將持續擴張。

技術創新在塑造經腸營養市場的未來方面發揮關鍵作用。配方科學的創新，例如針對特定疾病的專用配方的開發，正在提高經腸營養的有效性。此外，包裝和輸送系統的進步，包括即用型和攜帶式產品，正在提升經腸營養產品的便利性和可及性。隨著製造商持續加大研發投入，預計經腸營養市場將在包括醫院、長期照護機構和居家醫療在內的各種醫療機構中得到更廣泛的應用。

此外，以患者為中心的護理和個人化營養管理日益受到重視，這正推動經腸營養市場的發展。隨著患者及其看護者對自身營養需求的了解不斷加深，對能夠滿足個體偏好和飲食限制的經腸營養的需求也日益成長。這一趨勢促使製造商、醫療保健機構和營養師攜手合作，共同開發客製化解決方案，以提高患者滿意度和營養計劃的依從性。隨著市場的不斷發展，技術應用、個人化服務以及患者參與度的提升將是未來成功的關鍵。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 繪製滲透率和成長前景圖
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場問題
• 波特五力分析
• PESTLE分析

4. 全球經腸營養市場（依產品類型分類）

• 市場分析、洞察與預測
• 標準配方
• 疾病特異性配方
• 混合配方

第5章 全球經腸營養市場分階段分析

• 市場分析、洞察與預測
• 成人
• 兒童

6. 全球經腸營養市場（依形式分類）

• 市場分析、洞察與預測
• 液體
• 粉末

7. 全球經腸營養市場（依最終用戶分類）

• 市場分析、洞察與預測
• 醫院
• 居家照護
• 長期照護機構

8. 全球經腸營養市場（依通路分類）

• 市場分析、洞察與預測
• 醫院藥房
• 零售藥房
• 網路藥房

9. 全球經腸營養市場（依地區分類）

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商格局（基於現有資訊）
• 策略規劃

第11章 公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • NestlAfA（C）Health Science
  • Danone SA
  • Fresenius Kabi AG
  • Mead Johnson Nutrition Company
  • Meiji Holdings Co. Ltd
  • B. Braun Melsungen AG
  • Hormel Foods Corporation
  • Victus Inc
  • Nutritional Medicinals LLC
  • Kate Farms
  • Nutricia Advanced Medical Nutrition
  • Medline Industries Inc
  • Vitasoy International Holdings Limited
  • Nutritional Resources Inc

The Enteral Feeding Formulas Market size is expected to reach USD 12.52 Billion in 2034 from USD 7.30 Billion (2025) growing at a CAGR of 6.17% during 2026-2034.

The Enteral Feeding Formulas Market is experiencing significant growth as the demand for nutritional support for patients with swallowing difficulties or malnutrition increases. Enteral feeding formulas are specially designed to provide essential nutrients to individuals who cannot consume food orally, including those with chronic illnesses, neurological disorders, and post-surgical recovery. The rising prevalence of conditions such as cancer, stroke, and gastrointestinal disorders is driving the demand for enteral feeding solutions. As healthcare providers seek to ensure adequate nutrition for patients, the market for enteral feeding formulas is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the enteral feeding formulas market. Innovations in formulation science, such as the development of specialized formulas tailored to specific medical conditions, are enhancing the effectiveness of enteral nutrition. Additionally, advancements in packaging and delivery systems, including ready-to-use and portable options, are improving the convenience and accessibility of enteral feeding products. As manufacturers continue to invest in research and development, the enteral feeding formulas market is likely to see increased adoption across various healthcare settings, including hospitals, long-term care facilities, and home healthcare.

Moreover, the growing emphasis on patient-centered care and personalized nutrition is influencing the enteral feeding formulas market's growth trajectory. As patients and caregivers become more informed about nutritional needs, there is a rising demand for enteral formulas that cater to individual preferences and dietary restrictions. This trend is driving collaboration between manufacturers, healthcare providers, and nutritionists to develop customized solutions that enhance patient satisfaction and adherence to feeding regimens. As the market continues to evolve, the integration of technology, personalization, and patient engagement will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Standard Formulas
• Disease-Specific Formulas
• Blenderized Formulas

By Stage

• Adult
• Pediatric

By Form

• Liquid
• Powder

By End-User

• Hospitals
• Home Care
• Long-Term Care Facilities

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Abbott Laboratories, Nestl Health Science, Danone SA, Fresenius Kabi AG, Mead Johnson Nutrition Company, Meiji Holdings Co Ltd, B Braun Melsungen AG, Hormel Foods Corporation, Victus Inc, Nutritional Medicinals LLC, Kate Farms, Nutricia Advanced Medical Nutrition, Medline Industries Inc, Vitasoy International Holdings Limited, Nutritional Resources Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ENTERAL FEEDING FORMULAS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Standard Formulas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Disease-Specific Formulas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Blenderized Formulas Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ENTERAL FEEDING FORMULAS MARKET: BY STAGE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Stage
• 5.2. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ENTERAL FEEDING FORMULAS MARKET: BY FORM 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Form
• 6.2. Liquid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Powder Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ENTERAL FEEDING FORMULAS MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Home Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Long-Term Care Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ENTERAL FEEDING FORMULAS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Distribution Channel
• 8.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL ENTERAL FEEDING FORMULAS MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product Type
  • 9.2.2 By Stage
  • 9.2.3 By Form
  • 9.2.4 By End-user
  • 9.2.5 By Distribution Channel
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product Type
  • 9.3.2 By Stage
  • 9.3.3 By Form
  • 9.3.4 By End-user
  • 9.3.5 By Distribution Channel
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product Type
  • 9.4.2 By Stage
  • 9.4.3 By Form
  • 9.4.4 By End-user
  • 9.4.5 By Distribution Channel
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product Type
  • 9.5.2 By Stage
  • 9.5.3 By Form
  • 9.5.4 By End-user
  • 9.5.5 By Distribution Channel
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product Type
  • 9.6.2 By Stage
  • 9.6.3 By Form
  • 9.6.4 By End-user
  • 9.6.5 By Distribution Channel
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL ENTERAL FEEDING FORMULAS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott Laboratories
  • 11.2.2 NestlAfA(C) Health Science
  • 11.2.3 Danone S.A
  • 11.2.4 Fresenius Kabi AG
  • 11.2.5 Mead Johnson Nutrition Company
  • 11.2.6 Meiji Holdings Co. Ltd
  • 11.2.7 B. Braun Melsungen AG
  • 11.2.8 Hormel Foods Corporation
  • 11.2.9 Victus Inc
  • 11.2.10 Nutritional Medicinals LLC
  • 11.2.11 Kate Farms
  • 11.2.12 Nutricia Advanced Medical Nutrition
  • 11.2.13 Medline Industries Inc
  • 11.2.14 Vitasoy International Holdings Limited
  • 11.2.15 Nutritional Resources Inc